Bimodal solutions or twice-daily icodextrin to enhance ultrafiltration in peritoneal dialysis patients.
The efficacy and safety of icodextrin has been well established. In this paper, we will discuss the pharmacokinetics and biocompatibility of icodextrin and its clinical effect on fluid management in peritoneal dialysis patients. Novel strategies for its prescription for peritoneal dialysis patients with inadequate ultrafiltration are reviewed.
Hemodialysis Unit, Kyanous Stavros Patras, Germanou 115, 26225 Patras, Greece.
Periklis
P
Dousdampanis
Konstantina
K
Trigka
Joanne M
JM
Bargman